Lima Memorial Health System Logo
Approximate ER WAIT TIME WAIT TIME MACRO

Health Library

Hairy cell leukemia
     
Print-Friendly
Bookmarks

Hairy cell leukemia

Leukemic reticuloendotheliosis; HCL; Leukemia - hairy cell

 

Hairy cell leukemia (HCL) is an unusual cancer of the blood. It affects B lymphocytes, a type of white blood cell.

Causes

 

HCL is caused by the abnormal growth of certain B cells. The cells look "hairy" under the microscope because they have fine projections extending from their surface.

HCL usually leads to a low number of normal blood cells.

The cause of this disease is unknown. Certain genetic changes in the cancer cells may be the cause. It affects men more often than women. The average age of diagnosis is 55.

 

Symptoms

 

Symptoms of HCL may include any of the following:

  • Easy bruising or bleeding
  • Heavy sweating (especially at night)
  • Fatigue and weakness
  • Feeling full after eating only a small amount
  • Recurrent infections and fevers
  • Pain or fullness in the upper left belly (enlarged spleen)
  • Swollen lymph glands
  • Weight loss

 

Exams and Tests

 

During a physical exam, your health care provider may be able to feel a swollen spleen or liver. An abdominal CT scan or ultrasound may be done to evaluate this swelling.

Blood tests that may be done include:

  • Complete blood count (CBC) to check low levels of white and red blood cells, as well as platelets.
  • Blood tests and a bone marrow biopsy to check for hairy cells.

 

Treatment

 

Treatment may not be needed for the early stages of this disease. Some people may need an occasional blood transfusion.

If treatment is needed because of very low blood counts, chemotherapy medicines can be used.

In most cases, chemotherapy can relieve the symptoms for many years. When the signs and symptoms go away, you are said to be in remission. There are also now targeted treatment options available.

Removing the spleen may improve blood counts, but is unlikely to cure the disease. Antibiotics can be used to treat infections. People with low blood counts may receive growth factors and, possibly, transfusions.

 

Outlook (Prognosis)

 

About 50% of people with HCL can expect to live 10 years or longer after the diagnosis and treatment.

 

Possible Complications

 

The low blood counts caused by hairy cell leukemia can lead to:

  • Infections
  • Fatigue
  • Excessive bleeding

 

When to Contact a Medical Professional

 

Contact your provider if you have major bleeding. Also contact your provider if you have signs of infection, such as a persistent fever, cough, or general ill feeling.

 

Prevention

 

There is no known way to prevent this disease.

 

 

References

Brown JR. Chronic lymphocytic leukemia. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 169.

Geyer MB, Abdel-Wahab O, Tallman MS, Park JH. Hairy cell leukemia. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 100.

National Cancer Institute website. Hairy cell leukemia treatment (PDQ) health professional version. www.cancer.gov/types/leukemia/hp/hairy-cell-treatment-pdq. Updated February 21, 2025. Accessed May 22, 2026.

Ravandi F. Hairy cell leukemia. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 77.

BACK TO TOPText only

 
  • Bone marrow aspiration

    Bone marrow aspiration

    illustration

  • Hairy cell leukemia - microscopic view

    Hairy cell leukemia - microscopic view

    illustration

  • Enlarged spleen

    Enlarged spleen

    illustration

    • Bone marrow aspiration

      Bone marrow aspiration

      illustration

    • Hairy cell leukemia - microscopic view

      Hairy cell leukemia - microscopic view

      illustration

    • Enlarged spleen

      Enlarged spleen

      illustration

    A Closer Look

     

      Self Care

       

        Tests for Hairy cell leukemia

         
           

          Review Date: 5/1/2026

          Reviewed By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

          The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

          © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

          All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.
          © 1997- adam.comAll rights reserved.